SOST

There are 134 papers on SOST in aging research: 8 trials and 28 observational studies in people, 55 in animals, 4 in cells, 37 reviews. The newest story, Nov 7, 2026: “Genetic analysis links a blood fat particle to 60 proteins”.

Gene

134 papers study it25 findings

HGNCNCBI GeneTaxon

7 new papers in 30 daysSee all 134 papers on SOST

At a glance

The findings reach people, from one lab or study. 11 independent labs in 8 countries; 23 trials.

“the associations between the rs2023794-C and TBS were significant in the additive (β = 0.03, P= 4.7×10−5, PFDR= 0.0003) and dominant (β = 0.032, P= 5×10−5, PFDR= 0.0003) models.”
Sclerostin as a Genetic Determinant of Trabecular Bone Score in Postmenopausal Women: The Bushehr Elderly Health (BEH) ProgramIranian journal of public health2024doi:10.18502/ijph.v53i10.16724

None of its findings points the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 11 independent labs in 8 countries
  • 23 trials
  • Funders: Fondation Leducq and others
  • 3 of 15 findings with company ties
  • 22 of 23 trials sponsored by developers of drugs aimed at it
  • Human trial8
  • Humans28
  • Animals55
  • Cells4
  • In silico2

Interventions

4

Irisin

downin mice1

1 study
  1. Irisin decreases SOST in mice (aged mice).

    “Irisin decreased the number of osteoclasts (p = 0.0056), tartrate-resistant acid phosphatase positive (TRAP+) osteocytes (p = 0.0292), and Sost expression in the bone marrow (p = 0.026) and cortical bone (p = 0.032).”

    Animalsaged mices.c.bone marrow and cortical bone100 μg/kg/weekly8 months

    Irisin reduced bone loss and signs of muscle wasting in mice

    Journal of translational medicine

More on Irisin

Femoral fracture

upin mice1

1 study
  1. Femoral fracture increases SOST in lung, in both young and aged mice.

    “increased gene expression of sclerostin, a regulator of Wnt signaling”

    Animalsin lung, in both young and aged miceunilateral femur osteotomy with external fixationlungmales

    Femoral fracture leads to moderate pulmonary organ damage in aged mice and induces immune alterations

    Frontiers in immunology

More on Femoral fracture

Go 6976

downin human cells1

1 study
  1. Go 6976 decreases SOST in human cells (senescent human DFCs).

    “PKC inhibition promoted osteogenic differentiation and inhibits the expression of SOST and Parathyroid hormone-related protein (PTHLH).”

    Cellssenescent human DFCs

    Inhibition of protein kinase C activity enables mineralization of senescent dental follicle cells with almost no osteogenic differentiation potential

    Archives of oral biology

More on Go 6976

Bed rest

upin humans1

1 study
  1. Bed rest increases SOST in humans.

    “Sclerostin increased during BR across groups (P=0.016).”

    Human trial14 daysmales

    Markers of bone metabolism during 14 days of bed rest in young and older men

    Journal of musculoskeletal & neuronal interactions

More on Bed rest

Effects

13

Synaptic plasticity

downin reviews1

1 study
  1. SOST impairs synaptic plasticity (elevated sclerostin).

    “elevated sclerostin can cross the blood-brain barrier, promote amyloid-β peptide deposition, and impair synaptic plasticity by suppressing Wnt/β-catenin signalling”

    Reviewelevated sclerostinbrain

    Osteoporosis and Alzheimer's Disease: The Role of Sclerostin

    Current osteoporosis reports

Estimated heel bone mineral density

downin humans1

1 study
  1. SOST is linked with lower estimated heel bone mineral density in humans (SOST inhibition instrumented by B4GALNT3 genetic variants) (Proxied inhibition: β-coefficient=0.034, SE = 0.007).

    “The proxied SOST inhibition (instrumented by B4GALNT3 genetic variants) had a significant causal effect on increased eBMD”

    HumansSOST inhibition instrumented by B4GALNT3 genetic variants

    Proxied therapeutic inhibition on sclerostin and atrial fibrillation risk

    Communications medicine

Osteoporosis

no changein humans1

1 study
  1. SOST was not clearly linked with osteoporosis in humans.

    “None of the examined SNPs showed significant associations with osteoporosis status.”

    Humans

    Real-World Assessment of Osteoporosis-Related Polymorphisms: Negative Findings for Osteoporosis and an Exploratory Association with Vitamin D

    Life (Basel, Switzerland)

More on Osteoporosis

Bone formation

downin reviews1

1 study
  1. SOST inhibits bone formation.

    “Sclerostin is an osteocyte-derived Wnt antagonist, inhibits bone formation and is linked to impaired muscle regeneration.”

    Review

    Irisin, Sclerostin, and Inflammatory Axis: Implication in Bone-Muscle Wasting Diseases

    Cell biochemistry and function

Lipid and ceramide metabolism

downin mice1

1 study
  1. SOST impairs lipid and ceramide metabolism in mice (via adipocytic sclerostin loop3-LRP4 interaction).

    “specific blockade of adipocytic sclerostin loop3-LRP4 interaction attenuates the impairment effect of sclerostin on lipid and glucose metabolism in vitro and in vivo”

    Animalsvia adipocytic sclerostin loop3-LRP4 interaction

    Adipocytic sclerostin loop3-LRP4 interaction required by sclerostin to impair whole-body lipid and glucose metabolism

    Nature communications

More on Lipid and ceramide metabolism

Grip strength

downin silico1

1 study
  1. SOST impairs grip strength in silico.

    “Genetically predicted higher concentrations of SOST and lower concentrations of SPP1 also conferred a higher risk of falls and lowered grip strength.”

    In silico

    Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigation

    EBioMedicine

Bone mineral density

downin silico1

1 study
  1. SOST decreases bone mineral density in silico.

    “MR analysis also revealed a possible negative impact on bone mineral density (BMD) by genetically predicted higher levels of SOST, CCDC80, and TIMP4 (Metalloproteinase inhibitor 4).”

    In silico

    Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigation

    EBioMedicine

More on Bone mineral density

osteogenesis

downin mouse cells1

1 study
  1. SOST inhibits osteogenesis in BMSCs.

    “SOST overexpression inhibited BMSC cell proliferation and osteogenic differentiation.”

    Cellsin BMSCs

    The miR-665/SOST Axis Regulates the Phenotypes of Bone Marrow Mesenchymal Stem Cells and Osteoporotic Symptoms in Female Mice

    The American journal of pathology

Skeletal muscle

downin reviews1

1 study
  1. SOST impairs skeletal muscle.

    “some of these factors including sclerostin, RANKL, TGF-β, and TNF-α have detrimental effects on skeletal muscle.”

    Review

    Role of the Osteocyte in Musculoskeletal Disease

    Current osteoporosis reports

Valve interstitial cell contractility

upin mouse cells1

1 study
  1. SOST increases valve interstitial cell contractility in mouse cells (Shown by Sost knockout).

    “Null valve interstitial cells were shown to be less contractile than their WT counterparts.”

    CellsShown by Sost knockoutvalve interstitial cell

    Sclerostin ablation prevents aortic valve stenosis in mice

    American journal of physiology. Heart and circulatory physiology

All 13

Upstream

1

MIR665

downin mouse cells1

1 study
  1. MIR665 decreases SOST in BMSCs.

    “miR-665 targeted the Wnt signaling inhibitor sclerostin (SOST) and inhibited SOST mRNA and protein expression.”

    Cellsin BMSCs

    The miR-665/SOST Axis Regulates the Phenotypes of Bone Marrow Mesenchymal Stem Cells and Osteoporotic Symptoms in Female Mice

    The American journal of pathology

More on MIR665

Associations

7

Lacunar density

mixedin mice1

1 study
  1. SOST is associated with lacunar density in young mice.

    “Lacunar parameters were also affected due to Sost deletion, with altered lacunar density and volume in young mice, but these differences were not present in old mice.”

    Animalsin young micebone

    Sost deficiency leads to greater bone vascular porosity, but similar osteocyte lacunar properties with increasing age

    Bone reports

Vitamin D

downin humans1

1 study
  1. SOST is associated with vitamin D in humans (TC and CC genotype carriers vs TT carriers) (β = -4.836, p = 1.7 × 10−6).

    “the SOST variant demonstrated a statistically significant association with serum vitamin D concentration (β = -4.836, p = 1.7 × 10−6)”

    HumansTC and CC genotype carriers vs TT carriers

    Real-World Assessment of Osteoporosis-Related Polymorphisms: Negative Findings for Osteoporosis and an Exploratory Association with Vitamin D

    Life (Basel, Switzerland)

More on Vitamin D

Falls

upin silico1

1 study
  1. SOST raises the risk of falls in silico.

    “Genetically predicted higher concentrations of SOST and lower concentrations of SPP1 also conferred a higher risk of falls and lowered grip strength.”

    In silico

    Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigation

    EBioMedicine

Hip fracture

upin silico1

1 study
  1. SOST raises the risk of hip fracture in silico.

    “genetically predicted levels of SOST (Sclerostin), CCDC80 (Coiled-coil domain-containing protein 80), NT-proBNP (N-terminal prohormone brain natriuretic peptide), and BNP (Brain natriuretic peptide) were associated with risk of hip fracture.”

    In silico

    Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigation

    EBioMedicine

More on Hip fracture

Bone mineral density

upin humans1

1 study
  1. SOST is associated with bone mineral density in humans (loss-of-function mutations).

    “Loss-of-function mutations in SOST result in excessive bone growth, markedly increased bone density, and other skeletal abnormalities due to uncontrolled Wnt activity.”

    Reviewloss-of-function mutations

    Therapeutic targeting of Wnt antagonists by small molecules for treatment of osteoporosis

    Biochemical pharmacology

More on Bone mineral density

Trabecular bone score

upin humans1

1 study
  1. SOST is associated with trabecular bone score in humans (β = 0.03, P= 4.7×10−5).

    “the associations between the rs2023794-C and TBS were significant in the additive (β = 0.03, P= 4.7×10−5, PFDR= 0.0003) and dominant (β = 0.032, P= 5×10−5, PFDR= 0.0003) models.”

    Humansfemalesn = 1,071

    Sclerostin as a Genetic Determinant of Trabecular Bone Score in Postmenopausal Women: The Bushehr Elderly Health (BEH) Program

    Iranian journal of public health

More on Trabecular bone score

Insulin/IGF-1 signaling

mixedin mice1

1 study
  1. SOST is associated with insulin/IGF-1 signaling in mice (genetic mouse models of Sost gene deficiency).

    “Likewise, genetic mouse models of Sost gene deficiency indicate sclerostin influences adipocyte development and insulin signaling.”

    Reviewgenetic mouse models of Sost gene deficiency

    Endocrine Functions of Sclerostin

    Current opinion in endocrine and metabolic research

More on Insulin/IGF-1 signaling

Funding

1 grant since 2026

Japan Society for the Promotion of Science¥4.6M

Latest

Dec 2025: 3Jan 2026: 9Feb 2026: 8Mar 2026: 3Apr 2026: 2May 2026: 5Jun 2026: 5Jul 2026: 3Aug 2026: 4Sep 2026: 2Oct 2026: 3Nov 2026: 552 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Genetic analysis links a blood fat particle to 60 proteins

Among 28,949 UK Biobank participants without cardiovascular disease, genetic analysis linked a fat-carrying particle to 60 proteins associated with artery disease or…Among 28,949 UK Biobank participants without cardiovascular disease, genetic analysis linked a fat-carrying particle to 60 proteins associated with artery disease or heart-valve narrowing.

Mendelian randomization · 28,949 peopleMechanisms
Diabetes & Metabolism

Diabetes risk did not clearly differ between osteoporosis drugs

The hazard ratio for type 2 diabetes, comparing risk over time, was 0.93 for romosozumab versus denosumab, with no statistically clear difference.The hazard ratio for type 2 diabetes, comparing risk over time, was 0.93 for romosozumab versus denosumab, with no statistically clear difference.

See all 134 papers on SOST